MediFocus: Medical Devices for the Treatment of Obesity

NEW YORK, May 27, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediFocus: Medical Devices for the Treatment of Obesity
http://www.reportlinker.com/p01190435/MediFocus-Medical-Devices-for-the-Treatment-of-Obesity.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

MediFocus: Medical Devices for the Treatment of Obesity

Summary

The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement in recent decades, evolving to become the gold standard for proven treatment in the absence of effective pharmacotherapy, only 1% of obese patients opt for surgical intervention. Less-invasive that surgery, obesity treatment medical devices have seen notable advancement in recent years, and several technologies have gained international adoption; however, long-term efficacy is still lacking, prompting continued development and ever-changing market competition.

GlobalData has released its medical device report, "MediFocus: Medical Devices for the Treatment of Obesity". The report offers a comprehensive analysis of the global obesity medical device market, including development and approval of artificial fullness devices, deep brain stimulation devices, endoscopic surgical devices, gastric electrical stimulation devices, gastric emptying aspiration tools, malabsorption devices, neuronal blocking technology, and restrictive devices. Included within is an analysis of the pipeline and approved obesity treatment products, with a focus on safety, efficacy and commercial positioning, as well as an examination of companies currently active in the field. The report identifies and evaluates key trends and advances shaping the global obesity medical device market, highlighting testimonials from top physicians around the world who are already utilizing the devices, with a focus on next-generation technologies. The report provides insight into the competitive obesity medical device landscape, including new companies approaching commercialization and pipeline products in development. This report was built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of cardiovascular medical device experts.

Scope

- An overview of the international obesity treatment medical device landscape
- Investigation of current and future market competition for obesity medical devices
- Competitive assessment with device strengths and weaknesses analyzed
- Marketed and pipeline product profiles covering efficacy, safety, clinical study details, regulatory approvals, and commercial positioning
- Evaluation of technology trends to assess pipeline product strength
- Overview of all devices in development, including design considerations, efficacy reports, and physician perception
- Coverage of key market players with portfolio assessment and SWOT analysis
- Direct quotes from Key Opinion Leaders (KOL) currently using obesity medical devices

Reasons to buy

- Understand the trends shaping and driving the obesity medical device markets
- Realize device preferences of physicians who have performed dozens of implantations already
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth
- What's the next big thing in the global Obesity Medical Device market? Identify, understand and capitalize

Table of Contents

1 Table of Contents 4
1.1 List of Tables 7
2 Introduction 12
2.1 Catalyst 12
2.2 Related Reports 13
2.3 Upcoming Related Reports 13
3 Market Overview 14
3.1 Background 14
3.1.1 Overfed and Under-nurtured 14
3.1.2 Pharma Fails to Seize the Obesity Market, Leaves Void for Med-Tech to Fill 15
3.1.3 Surgery Remains the Gold Standard for Now 16
3.1.4 Diabetes Indications Further Fuel Obesity Medical Device Industry Growth 18
3.1.5 New Indications in Pediatrics 19
3.1.6 International Market Growth 19
3.1.7 High Costs and Evolving Reimbursement 20
3.1.8 Drivers Behind Device Adoption 21
4 Competitive Assessment 23
4.1 Overview 23
4.2 Artificial Fullness Devices 25
4.2.1 End Ball (Endalis Laboratory) 27
4.2.2 Obalon (Obalon Therapeutics) 28
4.2.3 Orbera (Allergan) 30
4.2.4 Heliosphere (Helioscopie) 33
4.2.5 ReShape Duo (ReShape Medical) 35
4.2.6 SatiSphere (EndoSphere) 36
4.2.7 Spatz 3 (Spatz Medical) 38
4.3 Endoscopic Surgical Devices 41
4.3.1 Intraluminal Stapler (Ethicon) 41
4.3.2 OverStitch (Apollo Endosurgery) 43
4.3.3 StomaphyX (EndoGastric Solutions) 45
4.4 Gastric Electrical Stimulation 47
4.4.1 Abiliti (IntraPace, Inc.) 49
4.4.2 DIAMOND Tantalus (MetaCure Inc.) 51
4.5 Gastric Emptying Aspiration Tools 53
4.5.1 AspireAssist (Aspire Bariatrics, Inc.) 53
4.6 Malabsorption Devices 55
4.6.1 EndoBarrier (GI Dynamics, Inc.) 55
4.7 Neuronal Blocking Technology 58
4.7.1 Vbloc Maestro System (EnteroMedics) 58
4.8 Restrictive Devices 59
4.8.1 AMI Band (Agency for Medical Innovation) 61
4.8.2 Bioring (Cousin Biotech) 63
4.8.3 Heliogast (Helioscopie) 65
4.8.4 Lap-Band (Allergan) 67
4.8.5 Midband (Medical Innovation Development) 71
4.8.6 MiniMizer Extra (Bariatric Solutions) 72
4.8.7 Swedish/Realize Band (Ethicon-Endosurgery) 74
5 Pipeline Products 77
5.1 Overview 77
5.2 Artificial Fullness Devices 78
5.2.1 Full Sense Device (BFKW) 78
5.2.2 TransPyloric Shuttle (Baronova) 79
5.3 Deep Brain Stimulation 81
5.3.1 Deep Brain Stimulation Device (NeuroSigma) 81
5.4 Endoscopic Surgical Devices 83
5.4.1 ACE Stapler (BaroSense) 83
5.4.2 RS2 Restore (CR Bard) 84
5.5 Malabsorption Devices 85
5.5.1 ValenTx (ValenTx) 85
5.6 Restrictive Devices 87
5.6.1 AMI B-Band (Agency for Medical Innovation) 87
5.6.2 AMI Basket (Agency for Medical Innovation) 88
5.6.3 TERIS (BaroSense, Inc.) 90
6 Current and Future Players 92
6.1 Overview 92
6.1.1 Medical Device Companies have Opportunity to Incorporate Lifestyle Programs 92
6.2 Company Profiles 94
6.2.1 Allergan 94
6.2.2 Apollo Endosurgery, Inc. 96
6.2.3 Aspire Bariatrics, Inc. 97
6.2.4 Agency for Medical Innovation 98
6.2.5 Bariatric Solutions 99
6.2.6 Baronova 100
6.2.7 BaroSense, Inc. 101
6.2.8 BFKW 102
6.2.9 Cousin Biotech 103
6.2.10 CR Bard 104
6.2.11 Endalis Laboratory 105
6.2.12 EndoGastric Solutions 106
6.2.13 EndoSphere, Inc. 107
6.2.14 EnteroMedics, Inc. 108
6.2.15 Ethicon Endo-Surgery 109
6.2.16 GI Dynamics 110
6.2.17 Helioscopie 111
6.2.18 IntraPace, Inc. 112
6.2.19 Medical Innovation Development 113
6.2.20 MetaCure Inc. 114
6.2.21 Obalon Therapeutics 115
6.2.22 ReShape Medical 116
6.2.23 Spatz Medical 117
6.2.24 ValenTx, Inc. 118
7 Appendix 119
7.1 Bibliography 119
7.2 Abbreviations 123
7.3 Definitions 124
7.4 Methodology 124
7.5 Coverage 125
7.6 Primary Research 125
7.7 Physicians and Specialists Included in this Study 126
7.8 Secondary Research 127
7.9 About the Authors 128
7.9.1 Analysts 128
7.9.2 Global Head of Healthcare 129
7.10 About GlobalData 130
7.11 Contact Us 130
7.12 Disclaimer 130

List of Tables

Table 1: Ideal Bariatric Treatment Attributes 23
Table 2: Obesity Treatment Marketed Devices by Type 24
Table 3: Product Profile – End Ball 27
Table 4: End Ball SWOT Analysis 28
Table 5: Product Profile – Obalon 28
Table 6: Obalon SWOT Analysis 30
Table 7: Product Profile – Orbera 30
Table 8: Orbera SWOT Analysis 32
Table 9: Product Profile – Heliosphere 33
Table 10: Heliosphere SWOT Analysis 34
Table 11: Product Profile – ReShape Duo 35
Table 12: ReShape Duo SWOT Analysis 36
Table 13: Product Profile – SatiSphere 36
Table 14: SatiSphere SWOT Analysis 37
Table 15: Product Profile – Spatz 38
Table 16: Spatz SWOT Analysis 40
Table 17: Product Profile – Intraluminal Circular Stapler 41
Table 18: Intraluminal Stapler SWOT Analysis 42
Table 19: Product Profile – OverStitch 43
Table 20: Overstitch SWOT Analysis 44
Table 21: Product Profile – StomaphyX 45
Table 22: StomaphyX SWOT Analysis 47
Table 23: Product Profile – Abiliti 49
Table 24: Abiliti SWOT Analysis 50
Table 25: Product Profile – DIAMOND Tantalus 51
Table 26: DIAMOND Tantalus SWOT Analysis 53
Table 27: Product Profile – AspireAssist 54
Table 28: AspireAssist SWOT Analysis 55
Table 29: Product Profile – EndoBarrier 56
Table 30: EndoBarrier SWOT Analysis 57
Table 31: Product Profile – Vbloc Maestro System 58
Table 32: Maestro System with Vbloc SWOT Analysis 59
Table 33: Product Profile – AMI Band 61
Table 34: AMI Band SWOT Analysis 62
Table 35: Product Profile – Bioring 63
Table 36: Bioring SWOT Analysis 64
Table 37: Product Profile – Heliogast 65
Table 38: Heliogast SWOT Analysis 67
Table 39: Product Profile – Lap-Band 67
Table 40: Lap-Band SWOT Analysis 70
Table 41: Product Profile – Midband 71
Table 42: Midband SWOT Analysis 72
Table 43: Product Profile – MiniMizer 72
Table 44: MiniMizer SWOT Analysis 74
Table 45: Product Profile – Swedish/Realize Band 74
Table 46: Swedish/Realize Band SWOT Analysis 76
Table 47: Obesity Treatment Pipeline Devices by Type 77
Table 48: Product Profile – Full Sense Device 78
Table 49: Full Sense Device SWOT Analysis 79
Table 50: Product Profile – TransPyloric Shuttle 80
Table 51: TransPyloric Shuttle SWOT Analysis 80
Table 52: Product Profile – Deep Brain Stimulation Device 81
Table 53: Deep Brain Stimulation Device SWOT Analysis 82
Table 54: Product Profile – ACE Stapler 83
Table 55: ACE Stapler SWOT Analysis 84
Table 56: Product Profile – RS2 Restore 84
Table 57: RS2 Restore SWOT Analysis 85
Table 58: Product Profile – ValenTx 86
Table 59: ValenTx SWOT Analysis 86
Table 60: Product Profile – AMI B-Band 87
Table 61: AMI B-Band SWOT Analysis 88
Table 62: Product Profile – AMI Basket 88
Table 63: AMI Basket SWOT Analysis 89
Table 64: Product Profile – TERIS 90
Table 65: TERIS SWOT Analysis 91
Table 66: Company Profile – Allergan 94
Table 67: Allergan SWOT Analysis 95
Table 68: Company Profile – Apollo Endosurgery 96
Table 69: Apollo Endosurgery SWOT Analysis 96
Table 70: Company Profile – Aspire Bariatrics, Inc. 97
Table 71: Aspire Bariatrics, Inc. SWOT Analysis 97
Table 72: Company Profile – Agency for Medical Innovation 98
Table 73: Agency for Medical Innovation SWOT Analysis 98
Table 74: Company Profile – Bariatric Solutions 99
Table 75: Bariatric Solutions SWOT Analysis 99
Table 76: Company Profile – Baronova 100
Table 77: Baronova SWOT Analysis 100
Table 78: Company Profile – BaroSense, Inc. 101
Table 79: BaroSense, Inc. SWOT Analysis 101
Table 80: Company Profile – BFKW 102
Table 81: BFKW SWOT Analysis 102
Table 82: Company Profile – Cousin Biotech 103
Table 83: Cousin Biotech SWOT Analysis 103
Table 84: Company Profile – CR Bard 104
Table 85: CR Bard SWOT Analysis 104
Table 86: Company Profile – Endalis Laboratory 105
Table 87: Endalis Laboratory SWOT Analysis 105
Table 88: Company Profile – EndoGastric Solutions 106
Table 89: EndoGastric Solutions SWOT Analysis 106
Table 90: Company Profile – EndoSphere, Inc. 107
Table 91: EndoSphere, Inc. SWOT Analysis 107
Table 92: Company Profile – EnteroMedics, Inc. 108
Table 93: EnteroMedics, Inc. SWOT Analysis 108
Table 94: Company Profile – Ethicon Endo-Surgery 109
Table 95: Ethicon Endo-Surgery SWOT Analysis 109
Table 96: Company Profile – GI Dynamics 110
Table 97: GI Dynamics SWOT Analysis 110
Table 98: Company Profile – Helioscopie 111
Table 99: Helioscopie SWOT Analysis 111
Table 100: Company Profile – IntraPace Inc. 112
Table 101: IntraPace Inc. SWOT Analysis 112
Table 102: Company Profile – Medical Innovation Development 113
Table 103: Medical Innovation Development SWOT Analysis 113
Table 104: Company Profile – MetaCure, Inc. 114
Table 105: MetaCure, Inc. SWOT Analysis 114
Table 106: Company Profile – Obalon Therapeutics 115
Table 107: Obalon Therapeutics SWOT Analysis 115
Table 108: Company Profile – ReShape Medical 116
Table 109: ReShape Medical SWOT Analysis 116
Table 110: Company Profile – Spatz Medical 117
Table 111: Spatz Medical SWOT Analysis 117
Table 112: Company Profile – ValenTx, Inc. 118
Table 113: ValenTx, Inc. SWOT Analysis 118

Companies Mentioned
Allergan
Apollo Endosurgery, Inc.
Aspire Bariatrics, Inc.
Agency for Medical Innovation
Bariatric Solutions
Baronova
BaroSense, Inc.
BFKW
Cousin Biotech
CR Bard
Endalis Laboratory
EndoGastric Solutions
EndoSphere, Inc.
EnteroMedics, Inc.
Eth

To order this report:
Pathology Industry: MediFocus: Medical Devices for the Treatment of Obesity

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker